What is the recommended antibiotic treatment for bacterial pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Bacterial Pharyngitis

For confirmed or suspected bacterial pharyngitis, amoxicillin or penicillin V for 10 days is the first-line treatment, with first-generation cephalosporins (cephalexin) for non-anaphylactic penicillin allergy and clindamycin for immediate/anaphylactic penicillin reactions. 1

First-Line Treatment Strategy

Most pharyngitis is viral and requires no antibiotics—watchful waiting with symptomatic treatment is the preferred initial approach. 1 However, when Group A Streptococcus (GAS) is confirmed or highly suspected, antibiotic treatment prevents rheumatic fever (73% risk reduction), suppurative complications like peritonsillar abscess (85% risk reduction), and acute otitis media (70% risk reduction). 1

Primary Antibiotic Choice

  • Amoxicillin 500 mg twice daily for 10 days (adults) or 50 mg/kg once daily for 10 days (children, maximum 1000 mg) is the preferred first-line treatment. 1, 2
  • Penicillin V is equally effective and remains the gold standard due to proven efficacy, narrow spectrum, safety, and low cost. 1
  • No penicillin-resistant GAS has ever been documented worldwide, making these agents reliably effective. 1, 3
  • The full 10-day course is essential—even though symptoms resolve in 24-48 hours, completing the course maximizes pharyngeal eradication and prevents rheumatic fever. 1, 4, 2

Treatment Algorithm for Penicillin-Allergic Patients

Non-Anaphylactic Penicillin Allergy

  • First-generation cephalosporins are the preferred alternative: cephalexin 500 mg twice daily for 10 days (adults) or 20 mg/kg twice daily for 10 days (children, maximum 500 mg/dose). 1, 4, 2
  • Cross-reactivity risk is only 0.1% in patients with non-severe, delayed penicillin reactions. 4
  • Cefadroxil 30 mg/kg once daily for 10 days is an alternative with once-daily dosing advantage. 4
  • Cephalosporins show lower relapse rates compared to penicillin (OR 0.55) with similar symptom resolution. 1

Immediate/Anaphylactic Penicillin Allergy

Patients with anaphylaxis, angioedema, respiratory distress, or urticaria within 1 hour of penicillin must avoid all beta-lactams including cephalosporins due to 10% cross-reactivity risk. 1, 4

  • Clindamycin 300 mg three times daily for 10 days (adults) or 7 mg/kg three times daily for 10 days (children, maximum 300 mg/dose) is the preferred choice. 1, 4, 2
  • Clindamycin has only ~1% resistance among GAS in the United States and demonstrates high efficacy even in chronic carriers. 4
  • Azithromycin 500 mg once daily for 5 days (adults) or 12 mg/kg once daily for 5 days (children, maximum 500 mg) is an acceptable alternative. 1, 4, 5
  • Clarithromycin 250 mg twice daily for 10 days (adults) or 7.5 mg/kg twice daily for 10 days (children, maximum 250 mg/dose) is another option. 1, 4

Critical Considerations for Macrolides

  • Macrolide resistance among GAS ranges from 5-8% in the United States but varies geographically—check local resistance patterns before prescribing. 1, 4
  • Azithromycin requires only 5 days due to prolonged tissue half-life, but has higher late bacteriologic recurrence rates (OR 1.31) compared to 10-day penicillin. 1, 4
  • Azithromycin showed 95% bacteriologic eradication at Day 14 versus 73% for penicillin V, but this dropped to 77% versus 63% at Day 30. 5
  • In areas with high macrolide resistance, cephalexin is preferred over macrolides for penicillin-allergic patients. 1, 4

Common Pitfalls to Avoid

  • Do NOT use cephalosporins in patients with immediate hypersensitivity reactions to penicillin—the 10% cross-reactivity risk is unacceptable. 1, 4
  • Do NOT shorten antibiotic courses below 10 days (except azithromycin's 5-day regimen)—this increases treatment failure and rheumatic fever risk. 1, 4, 2
  • Do NOT use trimethoprim-sulfamethoxazole or tetracyclines—they do not eradicate GAS and have high resistance rates. 1, 4
  • Do NOT prescribe broad-spectrum cephalosporins (cefdinir, cefpodoxime) when narrow-spectrum agents work—this unnecessarily increases cost and resistance selection. 3, 2
  • Do NOT use azithromycin as first-line therapy when penicillin/amoxicillin can be used—reserve it for documented penicillin allergy. 4, 2

Adjunctive Symptomatic Treatment

  • Acetaminophen or NSAIDs (ibuprofen) should be offered for moderate to severe symptoms or high fever. 4, 2
  • Avoid aspirin in children due to Reye syndrome risk. 4, 2
  • Corticosteroids are not recommended as adjunctive therapy. 4

Post-Treatment Considerations

  • Routine follow-up throat cultures or rapid antigen tests are NOT recommended for asymptomatic patients who completed therapy. 1, 4
  • Testing should only be considered in special circumstances such as patients with history of rheumatic fever. 4
  • Chronic carriers (positive culture without symptoms) generally do not require treatment—they are unlikely to spread infection or develop complications. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Strep Throat in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cefdinir for Streptococcal Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.